Sign In
Buy SIBN
$15.84
+0.630 (+4.14%)
At Close: Jun 18, 2026
Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 50%: Here's is How to Trade
01:55pm, Thursday, 11'th Aug 2022 Zacks Investment Research
The mean of analysts' price targets for Si-Bone (SIBN) points to a 49.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts
SI-BONE, Inc. (SIBN) CEO Laura Francis on Q2 2022 Results - Earnings Call Transcript
10:11pm, Monday, 08'th Aug 2022
SI-BONE, Inc. (NASDAQ:SIBN ) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Matt Bacso - IR, Gilmartin Group Laura Francis - Chief Executive Officer Anshul Maheshwari
Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates
09:35pm, Monday, 08'th Aug 2022 Zacks Investment Research
Si-Bone (SIBN) delivered earnings and revenue surprises of -10.20% and 1.85%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2022
08:02pm, Monday, 08'th Aug 2022 GlobeNewswire Inc.
SANTA CLARA, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported
Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates
06:48pm, Monday, 08'th Aug 2022
Si-Bone (SIBN) delivered earnings and revenue surprises of -10.20% and 1.85%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Sight Sciences, Inc. (SGHT) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
02:00pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Sight Sciences, Inc. (SGHT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Si-Bone (SIBN) to Report a Decline in Earnings: What to Look Out for
02:01pm, Monday, 01'st Aug 2022 Zacks Investment Research
Si-Bone (SIBN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Si-Bone (SIBN) to Report a Decline in Earnings: What to Look Out for
11:37am, Monday, 01'st Aug 2022
Si-Bone (SIBN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SI-BONE, Inc. Announces FDA Clearance for Expanded Indication of the iFuse-TORQ® Implant System
12:00pm, Monday, 13'th Jun 2022 GlobeNewswire Inc.
Use Includes Pelvic Fragility Fractures Use Includes Pelvic Fragility Fractures
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates
09:25pm, Monday, 09'th May 2022 Zacks Investment Research
Si-Bone (SIBN) delivered earnings and revenue surprises of -20.93% and 0.31%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
SI-BONE, Inc.'s (SIBN) CEO Laura Francis on Q1 2022 Results - Earnings Call Transcript
07:54pm, Monday, 09'th May 2022
SI-BONE, Inc. (NASDAQ:SIBN ) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Matt Basco - IR, Gilmartin Group Laura Francis - Chief Executive Officer Anshul Maheshwari - C
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates
06:48pm, Monday, 09'th May 2022
Si-Bone (SIBN) delivered earnings and revenue surprises of -20.93% and 0.31%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
ViewRay (VRAY) Reports Q1 Loss, Tops Revenue Estimates
09:35pm, Thursday, 05'th May 2022 Zacks Investment Research
ViewRay (VRAY) delivered earnings and revenue surprises of 12.50% and 13.55%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Nevro (NVRO) Reports Q1 Loss, Tops Revenue Estimates
10:25pm, Wednesday, 04'th May 2022 Zacks Investment Research
Nevro (NVRO) delivered earnings and revenue surprises of 11.71% and 2.02%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Si-Bone (SIBN) Q1 Earnings Expected to Decline
07:00pm, Monday, 02'nd May 2022 Zacks Investment Research
Si-Bone (SIBN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
